AGN-150998

· Allergan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGN-150998, covering 2015-06-18 to 2015-06-18. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD) [Phase 2]